Insider Trading & Ownership - Intellia Therapeutics Inc. (NTLA)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Intellia Therapeutics Inc.
Goto Prev, 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2024-01-08
Sale		 2024-01-10
4:15 pm		 Intellia Therapeutics Inc. NTLA Sepp-Lorenzino Laura
EVP, Chief Scientific Officer		 2,275 $28.87 $65,682 43,927
(Direct)		 View
2024-01-03
Sale		 2024-01-05
4:51 pm		 Intellia Therapeutics Inc. NTLA LEONARD JOHN M
President and CEO		 19,223 $29.46 $566,310 904,901
(Indirect
Direct)		 View
2024-01-03
Sale		 2024-01-05
4:50 pm		 Intellia Therapeutics Inc. NTLA Lebwohl David
EVP, Chief Medical Officer		 5,843 $29.46 $172,135 54,372
(Direct)		 View
2024-01-03
Sale		 2024-01-05
4:50 pm		 Intellia Therapeutics Inc. NTLA Sepp-Lorenzino Laura
EVP, Chief Scientific Officer		 5,532 $29.46 $162,973 46,202
(Direct)		 View
2024-01-03
Sale		 2024-01-05
4:49 pm		 Intellia Therapeutics Inc. NTLA Goddard Glenn
EVP, Chief Financial Officer		 5,365 $29.46 $158,053 40,585
(Direct)		 View
2024-01-03
Sale		 2024-01-05
4:46 pm		 Intellia Therapeutics Inc. NTLA Hicks Derek
EVP, Chief Business Officer		 3,877 $29.46 $114,216 36,987
(Direct)		 View
2024-01-03
Sale		 2024-01-05
4:45 pm		 Intellia Therapeutics Inc. NTLA BASTA JAMES
EVP, General Counsel		 3,805 $29.46 $112,095 51,474
(Direct)		 View
2024-01-03
Sale		 2024-01-05
4:44 pm		 Intellia Therapeutics Inc. NTLA Clark Eliana
EVP, Chief Technical Officer		 4,608 $29.5 $135,954 40,845
(Direct)		 View
2023-10-31
Sale		 2023-11-02
4:42 pm		 Intellia Therapeutics Inc. NTLA Bhanji Muna
Director		 265 $23.9 $6,334 11,996
(Direct)		 View
2023-07-31
Sale		 2023-08-02
5:19 pm		 Intellia Therapeutics Inc. NTLA Bhanji Muna
Director		 265 $42.33 $11,217 12,261
(Direct)		 View
2023-07-06
Sale		 2023-07-10
5:21 pm		 Intellia Therapeutics Inc. NTLA Bhanji Muna
Director		 1,867 $39.3 $73,373 12,526
(Direct)		 View
2023-07-03
Sale		 2023-07-06
3:34 pm		 Intellia Therapeutics Inc. NTLA Clark Eliana
EVP, Chief Technical Officer		 360 $40.51 $14,584 45,146
(Direct)		 View
2023-06-20
Sale		 2023-06-22
5:52 pm		 Intellia Therapeutics Inc. NTLA Clark Eliana
EVP, Chief Technical Officer		 5,000 $45 $225,000 102,896
(Direct)		 View
2023-03-02
Sale		 2023-03-03
5:10 pm		 Intellia Therapeutics Inc. NTLA BASTA JAMES
EVP, General Counsel		 1,088 $43.88 $47,741 89,953
(Direct)		 View
2023-01-04
Sale		 2023-01-06
5:39 pm		 Intellia Therapeutics Inc. NTLA Sepp-Lorenzino Laura
EVP, Chief Scientific Officer		 4,838 $37.82 $182,982 17,629
(Direct)		 View
2023-01-04
Sale		 2023-01-06
5:32 pm		 Intellia Therapeutics Inc. NTLA LEONARD JOHN M
President and CEO		 6,673 $37.21 $248,302 825,240
(Indirect
Direct)		 View
2023-01-04
Sale		 2023-01-06
5:29 pm		 Intellia Therapeutics Inc. NTLA Hicks Derek
EVP, Chief Business Officer		 1,812 $37.21 $67,425 17,306
(Direct)		 View
2023-01-04
Sale		 2023-01-06
5:26 pm		 Intellia Therapeutics Inc. NTLA Lebwohl David
EVP, Chief Medical Officer		 2,574 $37.21 $95,779 25,687
(Direct)		 View
2023-01-04
Sale		 2023-01-06
5:23 pm		 Intellia Therapeutics Inc. NTLA Goddard Glenn
EVP, Chief Financial Officer		 2,427 $37.21 $90,309 15,404
(Direct)		 View
2022-07-01
Sale		 2023-01-06
5:21 pm		 Intellia Therapeutics Inc. NTLA Clark Eliana
EVP, Chief Technical Officer		 2,028 $37.65 $76,357 14,473
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2024-03-01
Option Award		 2024-03-05
4:10 pm		 N/A
2034-02-28		 Intellia Therapeutics Inc. NTLA Goddard Glenn
EVP, Chief Financial Officer		 69,944 $0 110,529
(Direct)		 View
2024-01-01
Exercise		 2024-01-03
5:35 pm		 2024-01-01
2031-03-02		 Intellia Therapeutics Inc. NTLA Sepp-Lorenzino Laura
EVP, Chief Scientific Officer		 3,500 $0 55,234
(Direct)		 View
2024-01-01
Exercise		 2024-01-03
5:34 pm		 2024-01-01
2031-03-02		 Intellia Therapeutics Inc. NTLA Lebwohl David
EVP, Chief Medical Officer		 3,187 $0 63,404
(Direct)		 View
2024-01-01
Exercise		 2024-01-03
5:30 pm		 2024-01-01
2031-03-02		 Intellia Therapeutics Inc. NTLA LEONARD JOHN M
President and CEO		 7,848 $0 931,974
(Direct)		 View
2024-01-01
Exercise		 2024-01-03
5:28 pm		 2024-01-01
2031-03-02		 Intellia Therapeutics Inc. NTLA Goddard Glenn
EVP, Chief Financial Officer		 3,062 $0 49,014
(Direct)		 View
2023-06-20
Exercise		 2023-06-22
5:52 pm		 N/A
2030-02-02		 Intellia Therapeutics Inc. NTLA Clark Eliana
EVP, Chief Technical Officer		 5,000 $0 102,896
(Direct)		 View
2023-06-20
Exercise		 2023-06-22
5:52 pm		 N/A
N/A		 Intellia Therapeutics Inc. NTLA Clark Eliana
EVP, Chief Technical Officer		 5,000 $12.27 102,896
(Direct)		 View
2023-06-14
Option Award		 2023-06-16
4:30 pm		 N/A
2033-06-13		 Intellia Therapeutics Inc. NTLA CHASE WILLIAM J
Director		 4,120 $0 21,403
(Direct)		 View
2023-06-14
Option Award		 2023-06-16
4:29 pm		 N/A
2033-06-13		 Intellia Therapeutics Inc. NTLA Verwiel Frank
Director		 10,898 $0 18,189
(Direct)		 View
2023-06-14
Option Award		 2023-06-16
4:28 pm		 N/A
2033-06-13		 Intellia Therapeutics Inc. NTLA Keresty Georgia
Director		 10,898 $0 22,619
(Direct)		 View
2023-06-14
Option Award		 2023-06-16
4:28 pm		 N/A
2033-06-13		 Intellia Therapeutics Inc. NTLA GOODMAN JESSE
Director		 10,898 $0 18,189
(Direct)		 View
2023-06-14
Option Award		 2023-06-16
4:26 pm		 N/A
2033-06-13		 Intellia Therapeutics Inc. NTLA Crowley John F
Director		 10,898 $0 18,189
(Direct)		 View
2023-06-14
Option Award		 2023-06-16
4:26 pm		 N/A
2033-06-13		 Intellia Therapeutics Inc. NTLA Cohen Fred E
Director		 10,898 $0 48,189
(Direct)		 View
2023-06-14
Option Award		 2023-06-16
4:24 pm		 N/A
2033-06-13		 Intellia Therapeutics Inc. NTLA Bhanji Muna
Director		 10,898 $0 20,866
(Direct)		 View
2023-04-14
Option Award		 2023-04-18
5:04 pm		 N/A
2033-04-13		 Intellia Therapeutics Inc. NTLA CHASE WILLIAM J
Director		 25,414 $0 32,214
(Direct)		 View

Ownership		 2023-04-18
4:49 pm		 N/A
N/A		 Intellia Therapeutics Inc. NTLA CHASE WILLIAM J
Director		 0 $0 6,800
(Direct)		 View
2023-03-01
Option Award		 2023-03-03
5:31 pm		 N/A
2033-02-28		 Intellia Therapeutics Inc. NTLA Hicks Derek
EVP, Chief Business Officer		 56,845 $0 74,151
(Direct)		 View
2023-03-01
Option Award		 2023-03-03
5:20 pm		 N/A
2033-02-28		 Intellia Therapeutics Inc. NTLA Goddard Glenn
EVP, Chief Financial Officer		 66,318 $0 81,722
(Direct)		 View
2023-03-01
Option Award		 2023-03-03
5:18 pm		 N/A
2033-02-28		 Intellia Therapeutics Inc. NTLA LEONARD JOHN M
President and CEO		 219,667 $0 1,044,907
(Direct)		 View
2023-03-01
Option Award		 2023-03-03
5:15 pm		 N/A
2033-02-28		 Intellia Therapeutics Inc. NTLA Lebwohl David
EVP, Chief Medical Officer		 74,016 $0 99,703
(Direct)		 View
2023-03-01
Option Award		 2023-03-03
5:14 pm		 N/A
2033-02-28		 Intellia Therapeutics Inc. NTLA Sepp-Lorenzino Laura
EVP, Chief Scientific Officer		 72,240 $0 89,869
(Direct)		 View
2023-03-01
Option Award		 2023-03-03
5:12 pm		 N/A
2033-02-28		 Intellia Therapeutics Inc. NTLA Clark Eliana
EVP, Chief Technical Officer		 65,347 $0 79,820
(Direct)		 View
2023-03-01
Option Award		 2023-03-03
5:10 pm		 N/A
2033-02-28		 Intellia Therapeutics Inc. NTLA BASTA JAMES
EVP, General Counsel		 71,482 $0 89,953
(Direct)		 View
Goto Prev, 0, 1, 2, 3, 4, Next